Navigation Links
BiPar Names Hoyoung Huh, M.D., Ph.D. President and Chief Executive Officer
Date:2/14/2008

BRISBANE, Calif., Feb. 14 /PRNewswire/ -- BiPar Sciences, Inc., a privately held biopharmaceutical company developing novel cancer therapeutics, announced that Hoyoung Huh, M.D., Ph.D., has been appointed President and Chief Executive Officer and will commence his new role on March 3, 2008.

Dr. Huh previously served as Chief Operating Officer and Head of the Pegylation Business Unit at Nektar Therapeutics, a drug development company in the therapeutic areas of oncology, CNS/pain, diabetes and infectious diseases. At Nektar, Dr. Huh led significant, revenue-generating partnerships with major pharmaceutical companies including Amgen Inc., Bayer AG, Baxter International Inc., Bristol-Myers Squibb Co., Novartis AG and Roche Holding Ltd. Dr. Huh managed more than 500 employees across global sites in key functions including research, clinical development, manufacturing, marketing and business development. He was also instrumental in establishing multiple new product partnerships and led the acquisition and divestiture of several entities.

Prior to Nektar, Dr. Huh was a partner with McKinsey & Company, serving biotechnology, biopharmaceutical and healthcare clients in the United States, Europe and Asia. He has been an industry thought leader and frequent speaker on topics including licensing, mergers and acquisitions and innovative product development and commercialization strategies. Dr. Huh serves on the board of directors of BayBio, a biotechnology industry association, and Nektar Therapeutics.

"Hoyoung is ideally suited to lead BiPar through this period of expansion and change, with a robust Phase 2 program underway with BSI-201, a potential best-in-class cancer therapy," said G. Kirk Raab, chairman of BiPar, who had served as acting CEO prior to Dr. Huh's appointment. "His business development experience is exceptional, and there is no doubt that Hoyoung will maximize the value of BiPar's programs through rigorous clinical development and w
'/>"/>

SOURCE BiPar Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. WellGen, Inc. Names Robert M. Hellauer as Chief Financial Officer
2. Xenome Names Ian T. Nisbet, PhD as Chief Executive Officer
3. Profectus BioSciences Inc. Names Shawn Patrick OBrien CEO
4. VIA Pharmaceuticals Names Rebecca Taub Senior Vice President of Research and Development
5. CNS Response, Inc Completes Neuro-Therapy Clinic Acquisition; Names Daniel A. Hoffman, MD Chief Medical Officer
6. Premier Research Names Patrick Melvin as Senior Director, Clinical Trial Management
7. DuPont Names Nicholas Fanandakis as Group Vice President - DuPont Applied BioSciences
8. PAREXEL Names Biopharmaceutical Industry Executive Eduard E. Holdener to Board of Directors
9. Quintiles Names Kelly McKee Executive Director of Operations for Public Health and Government Services Unit
10. SRA Names Timothy J. Atkin Senior Vice President of Global Health Business; Appoints Mike Toner Global Health Unit Chief Financial Officer
11. Romark Laboratories Names Emmet B. Keeffe, M.D. Vice President and Chief Medical Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2008)...-- WuXi PharmaTech (NYSE:,WX), a lead...ce research,and development outsourcing company wi...y announced that it has appointed Mr. Bob Zhu as V.../www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO ...ked as Head of Asia Human,Resources with Electroni...
(Date:7/1/2008)...archers at The University of Texas at San Antonio ...Diseases and The University of Texas Health Scienc...a cell type believed to play a role in controlling... tularensis, a respiratory pathogen and bioterror...ings will be released this week in a journal artic...
(Date:7/1/2008)...wire/ -- Microfluidic Systems Inc.,(MFSI) announce...ement for,the production of Microfluidic - Bioagen...rd is the fourth in a series of funded phases by t...03. The continued funding,through March 2009, will...ems for extended field trials in key locations aro...
(Date:7/1/2008)...wswire/ -- To effectively measure,customer satisfa...ghest,rating of 3.93 out of 5 among customer servi...esearch study conducted by Best Practices, LLC,s G...cent of companies use this assessment tool, with,c...ing follow-up CSR phone,surveys at all. Instead, c...
Breaking Biology Technology:WuXi PharmaTech (NYSE: WX) Appoints Mr. Bob Zhu as VP of HR 2UTSA/UTHSCSA publish results on bio-threat agent 2Microfluidic Systems Receives Continued Funding From the Department of Homeland Security (DHS) Toward the Commercial Production of Autonomous Airborne Pathogen Detection Systems 2Microfluidic Systems Receives Continued Funding From the Department of Homeland Security (DHS) Toward the Commercial Production of Autonomous Airborne Pathogen Detection Systems 3Follow-up Phone Surveys: Effective Customer Service Assessment Tool for Improving Satisfaction 2
...t of a directive to provide $5 million in state fu...h, has announced the state will provide $1 million... by stem cell researcher James Thomson. , ,Thomson...who first isolated human embryonic stem cells, is ...ar Dynamics International . , ,The former company ...
... the company whose automated computer system helps... its market reach with a new acquisition. , ,Eagle...tions provider based here, acquired Equipsoft Cor...nt software vendor early this week. , ,"Equipsoft ...enterprises will result in a stronger presence in ...
...ek,s state biotechnology conference, former govern...unded a lot like a man with higher office on his m...s last elected governor of Wisconsin in 1998 and w...cretary in 2005 a bit disgruntled with the Bush W...ician whose time has passed. But the 2008 presiden...
...of Commerce has qualified seven small businesses ...nvestor and Venture Fund Tax Credit programs. , ,...stment in technology and biotechnology companies, ...ors and investors in seed-stage venture capital fu...n claim tax credits under the legislation that Go...
Other Biology Technology:State puts up $1 million for James Thomson's new stem cell startup 2State puts up $1 million for James Thomson's new stem cell startup 3Eagle Technology acquires some synergy 2Tommy Thompson's Iowa strategy isn't far-fetched 2Tommy Thompson's Iowa strategy isn't far-fetched 3Tommy Thompson's Iowa strategy isn't far-fetched 4Commerce qualifies seven for investor tax credits 2
(Date:7/2/2008)...tanding in a greenhouse at the University of Rhode...appeared that something had gone terribly wrong. ...last February in hundreds of small pots were dead....,t surprised. That,s because the pots had been si...s, and few varieties of grass can put up with that...
(Date:7/2/2008)...State University faculty member who uses computati...killing drugs is attracting worldwide attention fr...ant professor of chemical and biomedical engineeri...versity College of Engineering, is using high-powe... recombinant immunotoxins can best be modified in ...
(Date:7/2/2008)...t to produce a lot of a substance -- such as a new...molecules that speed chemical reactions. Many jobs... one in just the right shape to connect with certa...such as enzymes in the human body that help us dig...g to suit the task at hand. , Chemists have made...
(Date:7/2/2008)... July 1, 2008) To aid in the study of genetic ...ype Map Project have developed a haplotype map of ...erns of genetic variation. While data from the pr...om the project,s website ( www.hapmap.org) , the n... to master for the beginner. This month,s issue o...
Breaking Biology News(10 mins):Search for salt tolerant grasses aims to improve roadside plantings 2FSU researcher using computers to hone cancer-fighting strategies 2Synthetic molecules emulate enzyme behavior for the first time 2Synthetic molecules emulate enzyme behavior for the first time 3HapMap browsing and DDDP methods for genetic analysis featured in CSH Protocols 2Ultra Runner to Run 63 Marathons in 63 Days for Children with Incurable Disease 333 1Ultra Runner to Run 63 Marathons in 63 Days for Children with Incurable Disease 333 2Ultra Runner to Run 63 Marathons in 63 Days for Children with Incurable Disease 333 3Ultra Runner to Run 63 Marathons in 63 Days for Children with Incurable Disease 333 4Lake Elsinore Family Caregiver Receives Free Power Wheelchair From The SCOOTER Store 330 1Lake Elsinore Family Caregiver Receives Free Power Wheelchair From The SCOOTER Store 330 2Avicena Reports Second Quarter 2007 Results 294 1Avicena Reports Second Quarter 2007 Results 294 2Avicena Reports Second Quarter 2007 Results 294 3Avicena Reports Second Quarter 2007 Results 294 4Longaberger Expands Horizon of Hope Campaign to Build Support for American Cancer Societys Breast Cancer Initiatives 325 1Longaberger Expands Horizon of Hope Campaign to Build Support for American Cancer Societys Breast Cancer Initiatives 325 2Longaberger Expands Horizon of Hope Campaign to Build Support for American Cancer Societys Breast Cancer Initiatives 325 3
...s been successfully delivered into the tumors of ... administered lipid nanoparticle in a phase I clin...son Cancer Center. The gene, FUS1, also was found...g cancer tumors. , "We,ve treated 13 patients in t...ng proof of concept with no significant drug-relat...
...as A&M University and the University of Califo...e River National Wildlife Refuge to help natural s...Ornithology and the Arkansas Game and Fish Commiss...computer scientists ?Dr. Dezhen Song, assistant pr...Science, and Dr. Kenneth Y. Goldberg, professor in...
...someday find a cure for deafness. , As a leader in... Stanford University School of Medicine, he,s got ...ty. , It may take another decade or so, but if ... on. , "Everyone asks, ,How long before we do t...tolaryngology, whose accent still bears the trace...
...u, but serving them in daiquiri form may make them...g ways to help keep strawberries fresh during stor...ed that treating the berries with alcohol led to a...l scavenging activity within the fruit. While such... compounds would also be expected to make the stra...
Other Biology News:Intravenous nanoparticle gene therapy shows activity in stage IV lung cancer 2Computer scientists join in search for ivory-billed woodpecker 2Computer scientists join in search for ivory-billed woodpecker 3Stem cell transplants explored at Stanford as a possible treatment for hearing loss 2Stem cell transplants explored at Stanford as a possible treatment for hearing loss 3
Prolong Gold Antifade Reagent from Invitrogen
Cell Lysis Buffer is used to lyse cells under nondenaturing conditions.
LECHNER AND LaVECK MEDIUMfor the clonal growth of normal human bronchial and other epithelial cells. Requires additives. With glutamine.Recommended storage condition:oC to 8oCIntended use(s):research
Human Granulocyte Macrophage Colony Stimulating Factor, Unconjugated from PeproTech
Biology Products: